We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0QXX market cap is 908.33M. The company's latest EPS is CHF 3.2696 and P/E is 7.71.
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Revenue | 10.36M | 20.38M | 9.34M | 9.33M | 189.56M |
Operating Income | -37.41M | -36.66M | -58.33M | -63.42M | 116.61M |
Net Income | -37.04M | -36.29M | -62.76M | -63.79M | 117.85M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Assets | 155.16M | 104.94M | 187.55M | 172.67M | 262.26M |
Total Liabilities | 63.45M | 50.8M | 80.33M | 65.38M | 27.09M |
Total Equity | 91.7M | 54.14M | 107.22M | 107.29M | 235.17M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Operating | -42.47M | -1.19M | -28.98M | -90.95M | 118.57M |
Investing | 9.61M | -19.84M | -21.75M | -22.24M | -101.12M |
Financing | 392k | -227k | 113.2M | 50.58M | -1.57M |
Market Cap | 908.33M |
Price to Earnings Ratio | 7.71 |
Price to Sales Ratio | 4.79 |
Price to Cash Ratio | 10.33 |
Price to Book Ratio | 3.86 |
Dividend Yield | - |
Shares Outstanding | 36.05M |
Average Volume (1 week) | 519 |
Average Volume (1 Month) | 625 |
52 Week Change | 0.00% |
52 Week High | 25.20 |
52 Week Low | 25.20 |
Spread (Intraday) | 0 (0%) |
Company Name | Molecular Partners Ag |
Address |
wagistrasse 14 schlieren 8952 |
Website | https://www.molecularpartners.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions